sleep – SeroTalk / A podcast and interactive blog on the accessible digital lifestyle, produced by Serotek, the Accessibility Anywhere people Thu, 20 Oct 2011 14:04:11 +0000 en-US hourly 1 https://wordpress.org/?v=5.5.3 A podcast and interactive blog on the accessible digital lifestyle, produced by Serotek, the Accessibility Anywhere people SeroTalk no SeroTalk ricky.enger@serotek.com ricky.enger@serotek.com (SeroTalk) A podcast and interactive blog on the accessible digital lifestyle, produced by Serotek, the Accessibility Anywhere people SeroTalksleep – SeroTalk /wp-content/plugins/powerpress/rss_default.jpg / an Interview with Willie Hoos, Vanda Pharmaceuticals /2011/10/20/an-interview-with-willie-hoos-vanda-pharmaceuticals/ Thu, 20 Oct 2011 09:04:11 +0000 /?p=1317 Continue reading →]]> Interview with Willie Hoos, Vanda Pharmaceuticals

 

Listen to an interview with Willie Hoos of Vanda Pharmaceuticals

 

In this interview, Jamie Pauls speaks with Willie Hoos, who  discusses information about sleep disorders among the blind. Specifically, non-24-hour Sleep/Wake Disorder is explored. In addition to this interview, you can read the 5-part series in the Matilda Ziegler Magazine. You can also view SeroTalk Tech Chat 105, where this subject is discussed in detail.

 

If you’d like more information about non-24-hour sleep/wake disorder, please visit http://www.24sleepwake.com/. If you are interested in taking a short survey and learning more about participating in a clinical trial of medication that could address this disorder, please call (888) 389-7033.

 

 

]]> Interview with Willie Hoos, Vanda Pharmaceuticals -   - Listen to an interview with Willie Hoos of Vanda Pharmaceuticals -   - In this interview, Jamie Pauls speaks with Willie Hoos, who  discusses information about sleep disorders among the blind. Interview with Willie Hoos, Vanda Pharmaceuticals   Listen to an interview with Willie Hoos of Vanda Pharmaceuticals   In this interview, Jamie Pauls speaks with Willie Hoos, who  discusses information about sleep disorders among the blind. Specifically, non-24-hour Sleep/Wake Disorder is explored. In addition to this interview, you can read the 5-part series in the Matilda Ziegler Magazine. You can also view SeroTalk Tech Chat 105, where this subject is discussed in detail.   If you’d like more information about non-24-hour sleep/wake disorder, please visit http://www.24sleepwake.com./ If you are interested in taking a short survey and learning more about participating in a clinical trial of medication that could address this disorder, please call (888) 389-7033.     SeroTalk no